Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Begins Trading on Nasdaq

NEW YORK (GenomeWeb News) — Rosetta Genomics began trading on the New York Stock Exchange today at $7 per share with a total of 3.75 million shares.
The company’s bid price opened today at $7.02 and by mid-afternoon had climbed almost 7 percent to $7.50.


The Israeli company, which will trade on the Nasdaq Global Market under the symbol "ROSG," stated that set price in a release this morning before the opening bell.
It also said underwriters would have a 30-day option to buy as many as 562,500 shares to cover over-allotments.
When Rosetta filed with its initial public offering with the US Securities and Exchange Commission in September 2006, the company said it expected to sell 3 million shares priced between $11 and $13, which would have generated just under $45 million.
Last month, Rosetta lowered that price to between $7.50 and $8.50 in an amended filing, which would raise a total of around $30 million through the IPO and the over-allotment.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.